Pharmaceutical

Astellas licenses 4DMT’s AAV vector for ophthalmic targets

Astellas Pharma has entered into an agreement to license 4DMT's R100 vector for ...

BeiGene to acquire DualityBio’s ADC therapy for solid t...

BeiGene has signed an agreement with DualityBio for the acquisition of an exclus...

Elsie and GSK link to accelerate oligonucleotide discov...

Elsie has signed a research collaboration agreement with GSK to accelerate the d...

MHRA approves GSK’s RSV vaccine for older adults in the UK

The belated decision follows RSV vaccine approvals in America and the European U...

Virpax plans three trials based on platform drug delive...

Preclinical work is currently underway for all three candidates, with the first ...

Covid-19: Anti-inflammatory drugs do not lead to a swif...

Study shows patients taking abatacept, cenicriviroc, or Remicade in addition to ...

STAT+: The new weight loss drugs are revolutionizing ou...

Wegovy and similar drugs weren't originally designed to get into the brain. But ...

STAT+: New Biden initiative targets controversial hospi...

A new Biden administration initiative requires hospitals to “make information ab...

STAT+: Biden launches a new push to limit health care c...

President Biden on Friday rolled out a new set of initiatives to reduce health c...

STAT+: How the political right came to back psychedelic...

Growing awareness of the trauma suffered by U.S. veterans has driven a wave of s...

STAT+: HCA discloses massive data breach affecting 11 m...

It's likely the largest data breach ever reported by a health care provider.

STAT+: Pharmalittle: European regulator probes suicidal...

A new shortage of a type of penicillin crucial to the fight against syphilis is ...

Why nearly half of Americans with Parkinson’s don’t see...

A new analysis finds that 40% of Medicare beneficiaries living with Parkinson's ...

A rare disease has run through five generations of his ...

“It was a decision when I was dating: At what point do you tell someone that you...

Opinion: How ARPA-H can master the subtle art of risk-t...

How can ARPA-H determine which risks are worth taking?

STAT+: Blue Cross Blue Shield insurers keep winning fro...

A program that undergirds the Affordable Care Act’s health insurance marketplace...